← Leaderboards
Eleftherios Michailidis
Rockefeller University
$3,717,575
Attributed
$3,717,575
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,717,575 · 5
By mechanism
R01$1,381,244 · 1
DP1$1,120,539 · 1
R21$526,396 · 1
R56$510,306 · 1
F32$179,090 · 1
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- Charles M. Rice$80,497,748
- Jean-Laurent Casanova$36,806,361
- Jacinta Bustamante$1,271,250
- Marina Caskey$39,777,285
- Qian Zhang$1,359,757
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationChronic Hepatitis BViralHepatocyteMalignant Neoplasm Of LiverHepatitis B VirusNuclearAffectTranscriptomicsImmune ResponseCircular DnaMaintenanceResponseVirusVirus ReplicationCellsIn VitroCoculture TechniquesInfectionLiver CirrhosisPrimary Cell CulturesHumanized MouseChronicLiver
Grant awards (12)
A proteomics atlas of HIV/HBV infections for curing HBV$708,086
R01 · FY2025 · AI · contact PI
Impact of HIV co-infections and comorbidities on circadian rhythm in the liver$548,914
DP1 · FY2025 · DK · contact PI
A proteomics atlas of HIV/HBV infections for curing HBV$673,158
R01 · FY2024 · AI · contact PI
Impact of HIV co-infections and comorbidities on circadian rhythm in the liver$571,625
DP1 · FY2024 · DK · contact PI
Virus-host interactions for a cure against HBV$510,306
R56 · FY2024 · AI · contact PI
Primary cell culture models of HIV/HBV co-infection$195,625
R21 · FY2024 · AI · contact PI
Primary cell culture models of HIV/HBV co-infection$74,814
R21 · FY2024 · AI · contact PI
Primary cell culture models of HIV/HBV co-infection$21,207
R21 · FY2024 · AI · contact PI
Primary cell culture models of HIV/HBV co-infection$234,750
R21 · FY2023 · AI · contact PI
The role of innate immune response in HBV infection and persistence$63,078
F32 · FY2017 · DK · contact PI
The role of innate immune response in HBV infection and persistence$59,970
F32 · FY2016 · DK · contact PI
The role of innate immune response in HBV infection and persistence$56,042
F32 · FY2015 · DK · contact PI